DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy

Information source: Hospital de Clinicas de Porto Alegre
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Diabetes Mellitus; Arterial Hypertension

Intervention: Metformin (Drug); Glybenclamide (Drug); NPH insulin (Drug); Hydrochlorothiazide (Drug); Propranolol (Drug); Captopril (Drug); Amlodipine (Drug)

Phase: N/A

Status: Active, not recruiting

Sponsored by: Hospital de Clinicas de Porto Alegre

Official(s) and/or principal investigator(s):
Rogerio Friedman, MD, PhD, Principal Investigator, Affiliation: Hospital de Clinicas de Porto Alegre
Jorge L Gross, MD, PhD, Study Chair, Affiliation: Hospital de Clinicas de Porto Alegre

Summary

The aim of this study is to to analyze if it is possible to reach the goals of HbA1c <7. 0% and blood pressure <= 130/80 mm Hg in a cohort of patients with type 2 diabetes attending a primary care unit, using ony those resources available at the unit, and provided by the Brazilian National Health System. It is an open label, observational study, with a duration of 4-6 years. Patients attending a primary care outpatient facility will be sequentially included in the study provided they give consent. They will be followed on a monthly basis by a team of physicians and nurses. Glucose, A1c, Blood PRessure will be the outcomes.

Clinical Details

Official title: ANALYSIS OF THE EFFECTIVENESS OF A STAGED MANAGEMENT PROGRAM AIMED AT CONTROLLING BLOOD PRESSURE AND BLOOD GLUCOSE OF TYPE 2 DIABETIC PATIENTS USING EXCLUSIVELY THE RESOURCES AVAILABLE IN A PRIMARY CARE SETTING IN BRAZIL

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome:

Glycated hemoglobin A1c

Blood pressure

Secondary outcome:

24 hr blood glucose profile

Fasting blood glucose

Eligibility

Minimum age: 30 Years. Maximum age: 85 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Type 2 diabetes mellitus (WHO)

Exclusion Criteria:

- Terminal disease (renal, cancer, heart failure)

Locations and Contacts

Hospital de ClĂ­nicas de Porto Alegre, Porto Alegre, RS 90035-903, Brazil
Additional Information

Starting date: July 2006
Last updated: October 25, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017